11 news items
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
JAZZ
1 May 24
are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
JAZZ
24 Apr 24
to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
JAZZ
17 Apr 24
have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer
Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
JAZZ
10 Apr 24
Providing a diverse range of perspectives from bullish to bearish, 15 analysts have published ratings on Jazz Pharmaceuticals
Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
JAZZ
10 Apr 24
Thirteen abstracts underscore Jazz's diverse neuroscience portfolio
zb6v8rlvh8epw5eqhvq1de4umzdy7rdmiqwi9al ye9vk3i70nct913b
JAZZ
2 Apr 24
to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed
473q0yhyyi0la765ob2uua 0ppw71m03fg1
JAZZ
20 Mar 24
(NASDAQ:JAZZ), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent
60gxlqwnccm pz85wf70wmjcj4xbfybd1c70aj1hw5aad9on9j0mfco5g57
JAZZ
12 Mar 24
diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep
1iyfg9j49xbfxailsgqijjjf2vmb
JAZZ
27 Feb 24
of Jazz's Board seats are held by members of diverse communities: female, of color, and/or LGBTQIA
iajbh0vc4gpn3c12488g2cmy53otha t8t
JAZZ
21 Feb 24
for people with serious diseases—often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates
i96jiu10401vvk1o7lshs91ijjv7hd3jfzc1u2qrx
JAZZ
20 Feb 24
-changing medicines for people with serious diseases – often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines
- Prev
- 1
- Next